$8.17
0.131.62%
Last update: Nov 9, 7:56 PM
Iovance Biotherapeutics Inc
IOVANASDAQ
The average analyst price target for Iovance Biotherapeutics is $12.73, 54.9% above the current price. Of 13 analysts, 9 rate it Buy and 4 Hold. Targets range from $4 to $20. The latest change came on Nov 6, 2026, when Barclays raised its price target on Iovance Biotherapeutics from $18 to $19 and kept an Overweight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
